Cargando…
TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases
Nonalcoholic fatty liver disease (NAFLD) is found in up to 30% of the world’s population and can lead to hepatocellular carcinoma (HCC), which has a poor 5-year relative survival rate of less than 40%. Clinical therapeutic strategies are not very successful. The co-occurrence of metabolic disorders...
Autores principales: | Kim, Ji Eon, Kim, Eunmi, Lee, Jung Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369364/ https://www.ncbi.nlm.nih.gov/pubmed/35955521 http://dx.doi.org/10.3390/ijms23158387 |
Ejemplares similares
-
Amino acid transporters as tetraspanin TM4SF5 binding partners
por: Jung, Jae Woo, et al.
Publicado: (2020) -
Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis
por: Lee, Hyejin, et al.
Publicado: (2022) -
Liver‐originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance
por: Jung, Jae Woo, et al.
Publicado: (2022) -
TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes
por: Sun, Hyunseung, et al.
Publicado: (2021) -
N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)